Effects of intravenous acepromazine and butorphanol on propofol dosage for induction of anesthesia in healthy Beagle dogs

Abstract

ObjectiveTo determine the effects of intravenous (IV) premedication with acepromazine, butorphanol or their combination, on the propofol anesthetic induction dosage in dogs. Study designProspective, blinded, Latin square design. AnimalsA total of three male and three female, healthy Beagle dogs, aged 3.79 ± 0.02 years, weighing 10.6 ± 1.1 kg, mean ± standard deviation. MethodsEach dog was assigned to one of six IV treatments weekly: 0.9% saline (treatment SAL), low-dose acepromazine (0.02 mg kg–1; treatment LDA), high-dose acepromazine (0.04 mg kg–1; treatment HDA), low-dose butorphanol (0.2 mg kg–1; treatment LDB), high-dose butorphanol (0.4 mg kg–1; treatment HDB); and a combination of acepromazine (0.02 mg kg–1) with butorphanol (0.2 mg kg–1; treatment ABC). Physiologic variables and sedation scores were collected at baseline and 10 minutes after premedication. Then propofol was administered at 1 mg kg–1 IV over 15 seconds, followed by boluses (0.5 mg kg–1 over 5 seconds) every 15 seconds until intubation. Propofol dose, physiologic variables, recovery time, recovery score and adverse effects were monitored and recorded. Data were analyzed using mixed-effects anova (p < 0.05). ResultsPropofol dosage was lower in all treatments than in treatment SAL (4.4 ± 0.5 mg kg–1); the largest decrease was recorded in treatment ABC (1.7 ± 0.3 mg kg–1). Post induction mean arterial pressures (MAPs) were lower than baseline values of treatments LDA, HDA and ABC. Apnea and hypotension (MAP < 60 mmHg) developed in some dogs in all treatments with the greatest incidence of hypotension in treatment ABC (4/6 dogs). Conclusions and clinical relevanceAlthough the largest decrease in propofol dosage required for intubation was after IV premedication with acepromazine and butorphanol, hypotension and apnea still occurred.